Skip to content

Donepezil Attenuate Postoperative Cognitive Dysfunction

Donepezil Attenuate Postoperative Cognitive Dysfunction in Aged Patients- A Multi-center, Case Control, Randomized Clinical Trail

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02927522
Acronym
DAPOCD
Enrollment
550
Registered
2016-10-07
Start date
2018-09-01
Completion date
2021-12-31
Last updated
2020-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral Head Necrosis, Osteoarthritis, Rheumatoid Arthritis

Keywords

Postoperative Cognitive Dysfunction, Donepezil, Hip replacement, Knee replacement, Postoperative delirium

Brief summary

Postoperative cognitive dysfunction (POCD) occurs mainly in aged patients. POCD may increase the mortality and morbidity. However, the mechanism of POCD is not clear yet and no effective therapy method was proved. According to our previous study, the central cholinergic system impaired by the anesthesia and surgery play a very important role in the POCD and donepezil an acetylcholinesterase inhibitor can prevent the POCD after isoflurane anesthesia in aged mice. Donepezil is a commercial medicine used for the Alzheimer Disease, which is tolerable and has minimal adverse events. In present study a multi-center randomized case control study was conducted and we hypothesized that donepezil attenuate the POCD.

Interventions

DRUGDonepezil

Donepezil a cholinesterase inhibitor, 5mg(1 pill)/ day for 7 days Po, was administrated from the day before surgery.

DRUGPlacebo

Placebo, 1 pill/ day for 7 days Po, was administrated from the day before surgery.

Sponsors

Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
CollaboratorOTHER
RenJi Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Elder than 60 years old 2. Speak Chinese Mandarin 3. Those who will undergo knee or hip replacement 4. Signed the inform consent 5. American Society of Anesthesiologists classification I to III

Exclusion criteria

1. Existing cerebral disease, or have a history of neurological and psychiatric diseases including Alzheimer Disease, stroke, epilepsy and psychosis; 2. existing cognitive impairment as evidenced by Mini-Mental State Examination scores below 24; 3. several audition or vision disorder; 4. unwillingness to comply with the protocol or procedures. 5. Can not communicated with Chinese Mandarin 6. Existing bradycardiac arrhythmia(Heart rate \<60 bpm for any reasons) 7. Existing gastrointestinal ulcer 8. Existing urinary incontinence 9. Existing asthma or chronic obstructive pulmonary disease 10. Allegory to Donepezil

Design outcomes

Primary

MeasureTime frame
The incidence of POCD 7 days(or before leaving hospital ) after surgery7 days after surgery or before leaving hospital
The incidence of postoperative delirium after surgery1 to 7 days after surgery

Secondary

MeasureTime frame
POCD incidence 1 months after surgery1 months after surgery

Countries

China

Contacts

Primary ContactDiansan Su, M.D., Ph.D.
diansansu@yahoo.com+8618616514088

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026